Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease Progression × Conservative Treatment × Gynecologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 2 Uterine Cervical Dysplasia 1 Disease Progression 1

Interventions

tumor necrosis factor-alpha, CNGRC fusion protein, human 2 liposomal doxorubicin 2 Doxorubicin 2 niraparib 1 copanlisib 1 Standard of Care 1 Practice Guidelines as Topic 1 Palliative Care 1 Paclitaxel 1 Conservative Treatment 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02522585 2016-04-20

p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management

Parc de Salut Mar

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡